The Veterinary Resources Support Facility is operated out of the Department of Veterinary Sciences, a component of the M.D. Anderson Science Park. This CCSG-support CORE facility provides a cost-effective, Cancer Center-wide Rodent Serology Program that supports the health of rodent research colonies and the operation of SPF facilities throughout the institution, where utilization approaches 100,000 rodents per year. At the Science Park campus, serology and other forms of health and genetic assessment comprise the Rodent Health and Genetic Quality Assurance Program, integral to maintenance of 14,500 SPF rodents and the numerous inbred and transgenic breeding production colonies maintained at that campus. These programs provide animal health information that is vital to the utilization of defined animal models that are free of intercurrent disease or silent infections. These goals are particularly critical for complex cancer models in areas such as carcinogenesis, chemoprevention, and gene-, immuno-, biological-, and radio-therapy. The Veterinary Resources Support Facility also provides a clinical veterinarian (65%) that oversees the rodent facilities at both Science Park campuses, provides specialized research services, managed breeding production colonies, and assists MDACC investigators with custom polyclonal antisera production (cost recovered). We are requesting new funds to provide investigators with assistance in transgenic breeding management and PCR sample collection as part of the services of producing transgenic animals. An electronic communique for institutional transgenic users and mechanisms for re-deriving imported transgenics harboring pathogens will also be established.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016672-24
Application #
6101824
Study Section
Project Start
1999-07-01
Project End
2000-06-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
24
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Scruggs, Stacie; Mama, Scherezade K; Carmack, Cindy L et al. (2018) Randomized Trial of a Lifestyle Physical Activity Intervention for Breast Cancer Survivors: Effects on Transtheoretical Model Variables. Health Promot Pract 19:134-144
Wen, Juyi; Liu, Hongliang; Wang, Lili et al. (2018) Potentially Functional Variants of ATG16L2 Predict Radiation Pneumonitis and Outcomes in Patients with Non-Small Cell Lung Cancer after Definitive Radiotherapy. J Thorac Oncol 13:660-675
Rivera-Del Valle, Nilsa; Cheng, Tiewei; Irwin, Mary E et al. (2018) Combinatorial effects of histone deacetylase inhibitors (HDACi), vorinostat and entinostat, and adaphostin are characterized by distinct redox alterations. Cancer Chemother Pharmacol 81:483-495
Ohanian, Maro; Rozovski, Uri; Kanagal-Shamanna, Rashmi et al. (2018) MYC protein expression is an important prognostic factor in acute myeloid leukemia. Leuk Lymphoma :1-12
Roman-Gonzalez, Alejandro; Zhou, Shouhao; Ayala-Ramirez, Montserrat et al. (2018) Impact of Surgical Resection of the Primary Tumor on Overall Survival in Patients With Metastatic Pheochromocytoma or Sympathetic Paraganglioma. Ann Surg 268:172-178
Wang, Yugang; Guo, Yusong R; Xing, Dongming et al. (2018) Supramolecular assembly of KAT2A with succinyl-CoA for histone succinylation. Cell Discov 4:47
Okuno, Masayuki; Gourmard, Claire; Mizuno, Takashi et al. (2018) Pathological diaphragmatic invasion by colorectal liver metastases is associated with RAS mutation, peritoneal recurrence and worse survival. HPB (Oxford) 20:57-63
Naqvi, Kiran; Cortes, Jorge E; Luthra, Raja et al. (2018) Characteristics and outcome of chronic myeloid leukemia patients with E255K/V BCR-ABL kinase domain mutations. Int J Hematol 107:689-695
Bose, Prithviraj; Nazha, Aziz; Komrokji, Rami S et al. (2018) Mutational landscape of myelodysplastic/myeloproliferative neoplasm-unclassifiable. Blood 132:2100-2103
Loehrer, Andrew P; Chang, David C; Song, Zirui et al. (2018) Health Reform and Utilization of High-Volume Hospitals for Complex Cancer Operations. J Oncol Pract 14:e42-e50

Showing the most recent 10 out of 12418 publications